Boston Scientific Corporation (NYSE:BSX) is one of the best defensive stocks to buy, according to Steve Cohen. On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Perform and reiterated a $125 price target. Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech Image: Courtesy of Boston Scientific The upgrade comes as Oppenheimer views the company as one of the best large-cap MedTech growth stories owing to a robust merger and acquisition strat ...